John Trizzino, EVP, CBO and CFO at NOVAVAX INC (NVAX), sold 3,195 shares at $108.57 ($351K) on 2020-09-30, disclosed to the SEC on 2020-10-01.
Open-market sale of $351k NVAX by EVP, CBO and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.60 | 79 | $9K | 2.4% |
| 2 | $108.57 | 945 | $103K | 29.3% |
| 3 | $108.57 | 945 | $103K | 29.3% |
| 4 | $109.59 | 353 | $39K | 11.0% |
| 5 | $110.85 | 332 | $37K | 10.5% |
| 6 | $112.03 | 160 |
| $18K |
| 5.1% |
| 7 | $112.78 | 58 | $7K | 1.9% |
| 8 | $114.03 | 214 | $24K | 7.0% |
| 9 | $115.08 | 109 | $13K | 3.6% |
| Total | $109.73 avg | 3,195 | $351K | 100% |
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |